ANI Pharmaceuticals, Inc. (ANIP)
Makes generic and branded medicines including injectables and eye implants for hospitals and pharmacies.
$81.04+0.03%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+26.8%
The outlook
ANIP trades at $81.04 with analyst consensus leaning toward Buy, and the average price target sits roughly 36% above the current price. The stock sits near the midpoint of its 52-week range with mixed momentum against its moving averages, while a trailing P/E of 20.7 reflects moderate valuation relative to earnings.
What’s behind the score
Analyst consensusBuy — 1.6 avg of 8 analysts
Price trendMixed vs its moving averages
52-week range50% of the way from its 52-week low to high
Price targetAvg target +36% vs current price
Analyst price target
~12-month · 8 analysts$110.00average target+35.7% vs now
Now $81.04
Low $91.00High $124.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.84B
52-wk high
$99.50
52-wk low
$62.61
50-day avg
$81.01
200-day avg
$81.44
Trailing P/E
20.7